Skip to content
healthcare.dev
Get a free key

up and up naproxen sodium pm

NDC 11673-687, diphenhydramine hydrochloride, naproxen sodium, tablet, film coated, from Target Corporation.

Product NDC
11673-687
Status
Listed
Labeler
Target Corporation
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
ANDA
Application
ANDA208499
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/11673-687 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DIPHENHYDRAMINE HYDROCHLORIDE25 mg/1
  • NAPROXEN SODIUM220 mg/1

Pharmacologic classes

Anti-Inflammatory Agents, Non-Steroidal [CS]; Cyclooxygenase Inhibitors [MoA]; Histamine H1 Receptor Antagonists [MoA]; Histamine-1 Receptor Antagonist [EPC]; Nonsteroidal Anti-inflammatory Drug [EPC]

Package NDCNDC-11Package
11673-687-27116730687271 BOTTLE in 1 CARTON (11673-687-27) / 80 TABLET, FILM COATED in 1 BOTTLE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 11673-687 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/11673-687 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 11673-687. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.